Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
Daniel Stoessel(University of Potsdam), Walter Maetzler(Christian-Albrechts-Universität zu Kiel), D. Scheller, Dirk Walther(Max Planck Institute of Molecular Plant Physiology), Claudia Schulte(School of the Art Institute of Chicago), Christian Deuschle(German Center for Neurodegenerative Diseases), André Nogueira da Costa(UCB Pharma (Belgium)), Márcia Cristina Teixeira dos Santos(UCB Pharma (Belgium)), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Irene Rebollo‐Mesa(King's College London), Nicolas Schauer
Cited by 105
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846